P
Prelude Therapeutics Incorporated (PRLD)
NMS – Real Time Price. Currency in USD
4.64
-0.16 (-3.33%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
4.64
-0.16 (-3.33%)
At close: May 12, 2026, 4:00 PM EDT
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis (MF), polycythemia vera, and essential thrombocythemia (ET); KAT6A for the treatment of advanced breast cancer and other solid tumors; and mutated calreticulin degrader antibody conjugates to treat MF and ET. The company has collaboration with AbCellera Biologics to discover, develop, and commercialize novel degrader antibody conjugates. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
| Name | Position |
|---|---|
| Dr. Andrew P. Combs Ph.D. | Executive VP & Chief Chemistry Officer |
| Dr. Krishna Vaddi D.V.M., Ph.D. | Founder, CEO & Director |
| Dr. Madhu Pudipeddi Ph.D. | Senior Vice President of Technical Operations |
| Dr. Peggy A. Scherle Ph.D. | Chief Scientific Officer |
| Dr. Wan-Jen Hong M.D. | Senior Vice President of Clinical Development |
| Mr. Bryant David Lim J.D. | CFO, Chief Legal Officer & Corporate Secretary |
| Mr. Naveen Babbar Ph.D. | Senior Vice President of Translation Medicine |
| Mr. Robert A. Doody Jr. | Senior Vice President of Investor Relations |
| Ms. Aimee Crombie Ph.D. | Senior VP and Head of Strategic Planning & Operations |
| Ms. Michele Porreca M.B.A. | Chief People Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 10-Q | prld-20260331.htm |
| 2026-04-29 | DEFA14A | for_filing_2026_defa14a.htm |
| 2026-04-21 | 8-K | d131537d8k.htm |
| 2026-04-20 | 8-K | d135229d8k.htm |
| 2026-04-15 | 8-K | prld-20260415.htm |
| 2026-03-12 | 8-K | d916869d8k.htm |
| 2026-03-10 | S-8 | prld-20260310.htm |
| 2026-03-10 | 10-K | prld-20251231.htm |
| 2026-02-03 | 8-K | prld-20260129.htm |
| 2026-01-09 | 8-K | prld-20260109.htm |